An arrangement agreed between the supplier of a PBS-listed medicine and the Australian Government that adequately monitors identified risks (or undesired events such as cost-ineffective use or greater-than-expected use) and manages them by appropriate mechanisms for sharing the impact of these risks between the supplier and the government should they arise. CoA
Recently Added
- Giving input about what is funded on the Medicare Benefits Schedule
- Christmas Gift Guide 2022
- National Medicines Policy Review
- Patient Based Evidence: Using patient preference research for PBAC/MSAC Webinar Series 1 of 3
- Patient Based Evidence: Using Patient Reported Outcomes Measures (PROMs): Webinar Series 2 of 3